0001315406-14-000088.txt : 20141112
0001315406-14-000088.hdr.sgml : 20141111
20141112163301
ACCESSION NUMBER: 0001315406-14-000088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141111
FILED AS OF DATE: 20141112
DATE AS OF CHANGE: 20141112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO RAD LABORATORIES INC
CENTRAL INDEX KEY: 0000012208
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 941381833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 ALFRED NOBEL DR
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 5107247000
MAIL ADDRESS:
STREET 1: 1000 ALFRED NOBEL DR
CITY: HERCULES
STATE: CA
ZIP: 94547
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STARK JAMES R
CENTRAL INDEX KEY: 0001248083
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07928
FILM NUMBER: 141214523
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-11-11
0000012208
BIO RAD LABORATORIES INC
BIO, BIOB
0001248083
STARK JAMES R
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES
CA
94547
0
1
0
0
VP, Corporate Controller
Bio-Rad A Common Stock
2014-11-11
4
M
0
300
62.47
A
4257
D
Bio-Rad A Common Stock
2014-11-11
4
S
0
300
112.23
D
3957
D
Bio-Rad A Common Stock
2014-11-11
4
S
0
3357
112.56
D
600
D
Bio-Rad A Common Stock
2014-11-11
4
S
0
600
113.04
D
0
D
Non-Qualified Stock Option (right to buy)
62.47
2014-11-11
4
M
0
300
0
D
2016-04-03
Bio-Rad A Common Stock
300
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.86 to $112.83, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.94 to $113.09, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested in five equal annual installments beginning on April 3, 2007.
James R. Stark
2014-11-12